Clover Health is trading at $4.92 (+5.47%) after reporting $743.2 million in second-quarter revenue, $28 million in GAAP net income, and stronger-than-expected profitability. - Management raised 2026 revenue guidance to $2.92 billion–$3.00 billion. - Gross-profit, adjusted-EBITDA, GAAP-income, and membership targets also increased. - The move extends the August 5 earnings-driven rally in the open August 7 session; no separate major announcement was identified.